ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 13 Jun 2011
Last Applicant/ Owned by
Lilly Corporate Center
Indianapolis
IN
46285
Serial Number
77845745 filed on 09th Oct 2009
Registration Number
N/A
Correspondent Address
Robert E. Lee, Jr.
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
TEKTEP
pharmaceutical preparations for use in the treatment of diabetes; pharmaceutical preparations for use in the treatment of rheumatoid arthritis; pharmaceutical preparations for use in the treatment of Crohn's disease; pharmaceutical preparations for use in the treatment of psoriasis; pharmaceutical preparations for use in the treatment of autoimmune disorders; pharmaceutical preparations for use in Read More
Classification Information
Class [005]
Pharmaceutical Products
pharmaceutical preparations for use in the treatment of diabetes; pharmaceutical preparations for use in the treatment of rheumatoid arthritis; pharmaceutical preparations for use in the treatment of Crohn's disease; pharmaceutical preparations for use in the treatment of psoriasis; pharmaceutical preparations for use in the treatment of autoimmune disorders; pharmaceutical preparations for use in the treatment of cancer
Mark Details
Serial Number
No 77845745
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 13th Jun 2011 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 13th Jun 2011 | ABANDONMENT - NO USE STATEMENT FILED |
| 17th Nov 2010 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 16th Nov 2010 | EXTENSION 1 GRANTED |
| 16th Nov 2010 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 04th Nov 2010 | EXTENSION 1 FILED |
| 04th Nov 2010 | TEAS EXTENSION RECEIVED |
| 11th May 2010 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| 16th Mar 2010 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 16th Mar 2010 | PUBLISHED FOR OPPOSITION |